Yong Cao

1.4k total citations
48 papers, 1.0k citations indexed

About

Yong Cao is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, Yong Cao has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 14 papers in Physiology and 12 papers in Molecular Biology. Recurrent topics in Yong Cao's work include Asthma and respiratory diseases (12 papers), IL-33, ST2, and ILC Pathways (9 papers) and MicroRNA in disease regulation (8 papers). Yong Cao is often cited by papers focused on Asthma and respiratory diseases (12 papers), IL-33, ST2, and ILC Pathways (9 papers) and MicroRNA in disease regulation (8 papers). Yong Cao collaborates with scholars based in China, United States and Hong Kong. Yong Cao's co-authors include Jian Wu, Xiaodong Wang, Jian Yao, Xiaosong Gu, Yongjian Xu, Wen Hu, Weining Xiong, Cong‐Yi Wang, Huilong Chen and Jungang Xie and has published in prestigious journals such as Brain, Biochemical and Biophysical Research Communications and Journal of Allergy and Clinical Immunology.

In The Last Decade

Yong Cao

44 papers receiving 999 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong Cao China 16 273 237 202 192 179 48 1.0k
Arti V. Shinde United States 20 901 3.3× 196 0.8× 88 0.4× 434 2.3× 219 1.2× 26 2.1k
Hidetoshi Tsuda Japan 20 279 1.0× 96 0.4× 49 0.2× 356 1.9× 335 1.9× 58 1.2k
Sally M. Shalaby Egypt 26 431 1.6× 111 0.5× 49 0.2× 225 1.2× 201 1.1× 70 1.4k
Zhao Zheng China 22 629 2.3× 95 0.4× 42 0.2× 209 1.1× 109 0.6× 46 1.4k
Ting Tian China 20 377 1.4× 79 0.3× 80 0.4× 114 0.6× 92 0.5× 40 854
Rica Tanaka Japan 19 521 1.9× 59 0.2× 61 0.3× 354 1.8× 92 0.5× 58 1.5k
Daniela Nascimento Silva Brazil 19 259 0.9× 41 0.2× 113 0.6× 133 0.7× 122 0.7× 41 845
Amal S. El‐Shal Egypt 19 374 1.4× 70 0.3× 36 0.2× 184 1.0× 115 0.6× 36 936
J. Jasmin Brazil 16 247 0.9× 145 0.6× 71 0.4× 108 0.6× 34 0.2× 37 881
Zhongyu Liu China 22 693 2.5× 94 0.4× 99 0.5× 276 1.4× 91 0.5× 65 1.5k

Countries citing papers authored by Yong Cao

Since Specialization
Citations

This map shows the geographic impact of Yong Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Cao more than expected).

Fields of papers citing papers by Yong Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Cao. The network helps show where Yong Cao may publish in the future.

Co-authorship network of co-authors of Yong Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Cao. A scholar is included among the top collaborators of Yong Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Cao. Yong Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hou, Shaohua, Yu Sun, Lin Tang, et al.. (2025). Recent progress in developing ATR inhibitors as anticancer agents. Biochemical Pharmacology. 243(Pt 2). 117521–117521.
2.
Hu, Yinan, Jun Yu, Qi Wang, et al.. (2020). Tartrate-Resistant Acid Phosphatase 5/ACP5 Interacts with p53 to Control the Expression of SMAD3 in Lung Adenocarcinoma. Molecular Therapy — Oncolytics. 16. 272–288. 23 indexed citations
3.
Chen, Huilong, Bohua Fu, Zhen‐Li Huang, et al.. (2019). <p>LncRNAs NR-026690 and ENST00000447867 are upregulated in CD4<sup>+</sup> T cells in patients with acute exacerbation of COPD</p>. International Journal of COPD. Volume 14. 699–711. 12 indexed citations
4.
Chen, Huilong, Zhen‐Li Huang, Bohua Fu, et al.. (2018). Aberrantly expressed lncRNAs identified by microarray analysis in CD4+T cells in asthmatic patients. Biochemical and Biophysical Research Communications. 503(3). 1557–1562. 16 indexed citations
5.
Cao, Yong, Yan Lin, Dongxu Wang, et al.. (2018). Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells. Cancer Chemotherapy and Pharmacology. 82(6). 1081–1086. 12 indexed citations
6.
Cao, Yong & Pei-Ying Zhang. (2017). miRNAs in vascular integrity. Experimental and Therapeutic Medicine. 14(1). 473–477. 3 indexed citations
8.
Wang, Yi, Zhijun Zhang, Long He, et al.. (2016). Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macrophage Production. Molecular Therapy. 24(5). 915–925. 180 indexed citations
9.
Cheng, Sheng, Huilong Chen, Aili Wang, et al.. (2016). Blockade of IL-23 ameliorates allergic lung inflammation via decreasing the infiltration of Tc17 cells. Archives of Medical Science. 6(6). 1362–1369. 14 indexed citations
10.
Chen, Huilong, Sheng Cheng, Aili Wang, et al.. (2015). IL-21 does not involve in OVA-induced airway remodeling and chronic airway inflammation.. PubMed Central. 8(7). 10640–5. 7 indexed citations
11.
Cao, Yong, Xia Xu, & Peiying Zhang. (2015). Advances in the Traditional Chinese Medicine-Based Management of Viral Myocarditis. Cell Biochemistry and Biophysics. 73(1). 237–243. 8 indexed citations
12.
Wang, Aili, Zhengyun Wang, Yong Cao, et al.. (2015). CCL2/CCR2-Dependent Recruitment of Th17 Cells but Not Tc17 Cells to the Lung in a Murine Asthma Model. International Archives of Allergy and Immunology. 166(1). 52–62. 40 indexed citations
13.
Cao, Yong, Lin Hao, Conghui Han, & Pei-Ying Zhang. (2014). Protective Effects of Wusen Erlian Granules in Experimental Model of Viral Myocarditis. Cell Biochemistry and Biophysics. 71(2). 1129–1133. 2 indexed citations
14.
Cao, Yong, et al.. (2013). Beneficial effects of hyperosmotic perfusion in the myocardium after ischemia/reperfusion injury in isolated rat hearts. Brazilian Journal of Cardiovascular Surgery. 28(1). 54–60. 6 indexed citations
15.
Jin, Di, Ying Chen, Zhengyun Wang, et al.. (2011). Diagnostic value of interleukin 22 and carcinoembryonic antigen in tuberculous and malignant pleural effusions. Experimental and Therapeutic Medicine. 2(6). 1205–1209. 9 indexed citations
16.
Cao, Yong, Qingfeng Song, Chao Cao, et al.. (2010). Recombinant Adeno-Associated Virus Vector-Mediated Delivery of Antisense Interleukin-5 Gene Attenuates Airway Remodeling in Allergic Rats. International Archives of Allergy and Immunology. 154(3). 207–215. 5 indexed citations
17.
Cao, Yong, Daxiong Zeng, Qingfeng Song, et al.. (2010). The effects of antisense interleukin-4 gene transferred by recombinant adeno-associated virus vector on the airway remodeling in allergic rats. Journal of Asthma. 47(9). 951–958. 12 indexed citations
18.
Cao, Yong, et al.. (2009). Effects of antisense interleukin‐5 gene transferred by recombinant adeno‐associated virus to allergic rats. Respirology. 15(1). 132–140. 5 indexed citations
19.
Tang, Yijun, Yongjian Xu, Shengdao Xiong, et al.. (2007). The effect of Ginkgo Biloba Extract on the expression of PKCα in the inflammatory cells and the level of IL-5 in induced sputum of asthmatic patients. Journal of Huazhong University of Science and Technology [Medical Sciences]. 27(4). 375–380. 13 indexed citations
20.
Cao, Yong. (2004). Study on drug resistance reversion and mechanism of bushen huayu jiedu formula in lung cancer cells of drug resistance. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026